100,000 Genomes Project

Last updated

100,000 Genomes Project
Project typeGovernment
Funding agency
Reference doi:10.1136/bmj.k1687
Project coordinator Genomics England
Partners
DurationJuly 2013 – December 2018
Website www.genomicsengland.co.uk/about-genomics-england/the-100000-genomes-project/

The 100,000 Genomes Project is a now-completed UK Government project managed by Genomics England that is sequencing whole genomes from National Health Service patients. The project is focusing on rare diseases, some common types of cancer, and infectious diseases. [1] [2] Participants give consent for their genome data to be linked to information about their medical condition and health records. The medical and genomic data is shared with researchers to improve knowledge of the causes, treatment, and care of diseases. [3] The project has received over £300 million from public and private investment. [4]

Contents

History

The project was first announced by UK Prime Minister David Cameron in December 2012. [5] The Government set up a new company Genomics England to oversee the project [2] with the plan to focus on rare diseases, cancer, and infectious diseases announced by Health Secretary Jeremy Hunt in July 2013. The project was also made possible by the National Institute for Health and Care Research (NIHR), NHS England, Public Health England, and Health Education England. In 2015, Northern Ireland [6] and Scotland [7] also joined the project with plans to start work the following year. In 2016, the Welsh government issued a statement of intent [8] and is considering participating in the 100,000 Genomes Project. [7]

The initial participants were recruited from Cambridge University Hospitals, University College London Partners, and Newcastle upon Tyne NHS Foundation Trust. The following medical centres joined the project a short time later: Central Manchester University Hospitals NHS Foundation Trust, Great Ormond Street Hospital, Guy's and St Thomas' NHS Foundation Trust, Moorfields Eye Hospital NHS Foundation Trust and Oxford University Hospitals NHS Trust. [9] In total, the coordination of recruitment for the 100,000 Genome Project was overseen by 13 Genomic Medicine Centers that have been established across 85 NHS Trusts in England, Northern Ireland, and Scotland. [10]

In September 2015, Genomics England announced it had contracted with interpretation partners Congenica and Omicia. This is in addition to ongoing work with sequencing partner Illumina. [11]

As of 1 October 2018, the 100,000 Genomes Project had completed the sequencing of 87,231 whole genomes in England [12] and results are in the process of being returned to NHS Genomic Medicine Centres and ultimately back to participants; the first diagnoses from the Project were returned to patients in spring 2015 and over 2,000 families' results have been returned to the NHS in the rare disease programme to date (July 2017). [13]

In December 2018, the full 100,000 genomes milestone was reached. [14]

In July 2019, Genomics England announced Data Release 7, which included the 100,000th whole genome made available to researchers. [15]

A 2019 review identified the initiative as an 'exemplar' in involving the public in genomic research. [16]

In June 2020, Lifebit, a UK-based biotechnology company, was announced as the provider of the trusted research environment that will link the genomic data gathered as part of the 100,000 Genome Project with academic research institutions. [17] [18]

NHS Genomic Medicine Centres

Research

The Genomics England Clinical Interpretation Partnership (GeCIP) includes 2,500 UK and international clinicians and scientists from approximately 300 institutions in 24 countries. There are plans to increase this number. Researchers are organised in "domains" formed around particular conditions, cancer types and research areas such as Machine Learning and Health Economics. The partnership is integrated with the NHS and the aims include improving the use of genotype and phenotype data in healthcare, and providing a platform for genomic research collaborations to add to the knowledge base for genetic disorders. [19] [20]

GenOMICC study on COVID-19

The 100,000 Genomes Project provided a pre-COVID reference set in the GenOMICC study on COVID-19. Genomics England worked in partnership with the GenOMICC consortium, led by the University of Edinburgh, to analyse the whole genome sequences of approximately 20,000 people who have been severely affected by COVID-19. This data was compared with 15,000 other genomes from people who were only mildly affected. It was combined with data set which now includes more than 120,000 genomes (from the "100,000 Genomes" Project). The 100,000 Genomes Project was referred to as the "incredibly important" pre-COVID reference set. [21]

See also

Related Research Articles

<span class="mw-page-title-main">BGI Group</span> Chinese genome sequencing company

BGI Group, formerly Beijing Genomics Institute, is a Chinese genomics company with headquarters in Yantian, Shenzhen. The company was originally formed in 1999 as a genetics research center to participate in the Human Genome Project. It also sequences the genomes of other animals, plants and microorganisms.

<span class="mw-page-title-main">UK Biobank</span> Long-term biobank study of 500,000 people

UK Biobank is a large long-term biobank study in the United Kingdom (UK) which is investigating the respective contributions of genetic predisposition and environmental exposure to the development of disease. It began in 2006. UK Biobank has been cited as an important resource for cancer research.

deCODE genetics is a biopharmaceutical company based in Reykjavík, Iceland. The company was founded in 1996 by Kári Stefánsson with the aim of using population genetics studies to identify variations in the human genome associated with common diseases, and to apply these discoveries "to develop novel methods to identify, treat and prevent diseases."

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

Cambridge University Hospitals NHS Foundation Trust is a British public sector healthcare provider located in Cambridge, England. It was established on 4 November 1992 as Addenbrooke's National Health Service Trust, and authorised as an NHS foundation trust under its current name on 1 July 2004.

Liverpool Women's NHS Foundation Trust runs Liverpool Women's Hospital, a major obstetrics, gynaecology and neonatology research hospital in Liverpool, England. It is one of several specialist hospitals located within the Liverpool City Region; alongside Alder Hey Children's Hospital, Liverpool Heart and Chest Hospital, the Walton Centre, Mersey Regional Burns and Plastic Surgery Unit, and Clatterbridge Cancer Centre.

Imperial College Healthcare NHS Trust is an NHS trust based in London, England. It is one of the largest NHS trusts in England and together with Imperial College London forms an academic health science centre.

Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips, or partial or full genome sequencing. Once the genotypes are known, the individual's variations can be compared with the published literature to determine likelihood of trait expression, ancestry inference and disease risk.

<span class="mw-page-title-main">Whole genome sequencing</span> Determining nearly the entirety of the DNA sequence of an organisms genome at a single time

Whole genome sequencing (WGS), also known as full genome sequencing, complete genome sequencing, or entire genome sequencing, is the process of determining the entirety, or nearly the entirety, of the DNA sequence of an organism's genome at a single time. This entails sequencing all of an organism's chromosomal DNA as well as DNA contained in the mitochondria and, for plants, in the chloroplast.

<span class="mw-page-title-main">Earlham Institute</span> Life science research institute in Norwich, England

Earlham Institute is a life science research institute located at the Norwich Research Park (NRP), Norwich, England. EI's research is focused on exploring living systems by applying computational science and biotechnology to answer ambitious biological questions and generate enabling resources.

Dr Vinod Scaria FRSB, FRSPH is an Indian biologist, medical researcher pioneering in Precision Medicine and Clinical Genomics in India. He is best known for sequencing the first Indian genome. He was also instrumental in the sequencing of The first Sri Lankan Genome, analysis of the first Malaysian Genome sequencing and analysis of the Wild-type strain of Zebrafish and the IndiGen programme on Genomics for Public Health in India.

Oxford University Hospitals NHS Foundation Trust is an English teaching hospital and part of the Shelford Group. It is one of the UK's largest teaching hospitals and one of the largest hospitals in Europe. The trust is made up of four hospitals – the John Radcliffe Hospital, the Churchill Hospital and the Nuffield Orthopaedic Centre, all located in Oxford, and the Horton General Hospital in Banbury, north Oxfordshire.

<span class="mw-page-title-main">Great Ormond Street Hospital for Children NHS Foundation Trust</span>

Great Ormond Street Hospital for Children NHS Foundation Trust runs Great Ormond Street Hospital. It is closely associated with University College London (UCL) and in partnership with the UCL Institute of Child Health, which it is located adjacent to, is the largest centre for research and postgraduate teaching in children’s health in Europe. It is part of both the Great Ormond Street Hospital/UCL Institute of Child Health Biomedical Research Centre and the UCL Partners academic health science centre.

<span class="mw-page-title-main">Genomics England</span> British company

Genomics England is a British company set up and owned by the United Kingdom Department of Health and Social Care to run the 100,000 Genomes Project. The project aimed in 2014 to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.

Sharon Jayne Peacock is a British microbiologist who is Professor of Public Health and Microbiology in the Department of Medicine at the University of Cambridge. Peacock also sits on Cambridge University Council.

Sophia Genetics is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. It provides genomic and radiomic analysis for hospitals, laboratories, and biopharma institutions. The company was ranked among the 50 smartest companies by the MIT Technology Review in 2017. The company went public on the Nasdaq in 2021, floating at $1.1B.

<span class="mw-page-title-main">Helmy Eltoukhy</span> American scientist and entrepreneur

Helmy Eltoukhy is an American scientist and a businessperson who co-founded startups Avantome and Guardant Health. He is best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. His startups were acquired by Illumina in 2008. Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome. Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research.

<span class="mw-page-title-main">Christine Patch</span> Nurse and genetic counsellor

Christine Patch is a nurse and genetic counsellor. She is a Principal Staff Scientist in Genomic Counselling in the Society and Ethics Research group, part of Wellcome Connecting Science, based on the Wellcome Genome Campus. She is also the Clinical Lead for Genetic Counselling at Genomics England, and a former President of the European Society of Human Genetics.

<span class="mw-page-title-main">COVID-19 Genomics UK Consortium</span> British genomics research consortium

The COVID-19 Genomics UK (COG-UK) consortium was a group of academic institutions and public health agencies in the United Kingdom created in April 2020 to collect, sequence and analyse genomes of SARS-CoV-2 at scale, as part of COVID-19 pandemic response.

Dame Lyn Susan Chitty is a British physician and Professor of Genetics and Fetal Medicine at University College London. She is the deputy director of the National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre. She is the 2022 president of the International Society for Prenatal Diagnosis. Her research considers non-invasive prenatal diagnostics. She was made a Dame in the 2022 New Year Honours.

References

  1. ↑ Ramesh, Randeep (5 July 2013). "Jeremy Hunt launches genomics body to oversee healthcare revolution". The Guardian. Retrieved 12 September 2014.
  2. 1 2 Department of Health and Social Care (5 July 2013). "DNA mapping to better understand cancer, rare diseases and infectious diseases" (Press release). UK Government. Archived from the original on 20 March 2016. Retrieved 26 May 2016.
  3. ↑ "Data access, security and privacy". Genomics England. 10 March 2015. Archived from the original on 5 June 2016. Retrieved 6 June 2016.
  4. ↑ McKee, Selina (1 August 2014). "£300m for UK 100,000 genomes project - PharmaTimes". pharmatimes.com. Archived from the original on 12 January 2024. Retrieved 12 January 2024.
  5. ↑ "DNA tests to revolutionise fight against cancer and help 100,000 NHS patients". UK Government. 10 December 2012. Archived from the original on 3 June 2016. Retrieved 26 May 2016.
  6. ↑ "Northern Ireland joins the 100,000 Genomes Project". Genomics England. 29 October 2015. Archived from the original on 19 August 2016. Retrieved 8 September 2016.
  7. 1 2 "Scottish investment in genomic medicine". Genomics England. 1 March 2016. Archived from the original on 14 September 2016. Retrieved 8 September 2016.
  8. ↑ "Written Statement -Statement of Intent for Genomics and Precision Medicine". The Welsh Government. Archived from the original on 13 September 2016. Retrieved 8 September 2016.
  9. ↑ The 100,000 Genomes Project Pilot Investigators (11 November 2021). "100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report". New England Journal of Medicine. 385 (20): 1868–1880. doi:10.1056/NEJMoa2035790. ISSN   0028-4793. PMC   7613219 . PMID   34758253.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  10. ↑ Wheway, Gabrielle; Genomics England Research Consortium; Mitchison, Hannah M.; Ambrose, J. C.; Baple, E. L.; Bleda, M.; Boardman-Pretty, F.; Boissiere, J. M.; Boustred, C. R.; Caulfield, M. J.; Chan, G. C.; Craig, C. E. H.; Daugherty, L. C.; de, Burca A.; Devereau, A. (2019). "Opportunities and Challenges for Molecular Understanding of Ciliopathies–The 100,000 Genomes Project". Frontiers in Genetics. 10: 127. doi: 10.3389/fgene.2019.00127 . ISSN   1664-8021. PMC   6421331 . PMID   30915099.
  11. ↑ "Genomics England announces interpretation partners and expands industry engagement | Genomics England". 30 September 2015. Archived from the original on 9 October 2016. Retrieved 16 September 2016.
  12. ↑ "The 100,000 Genomes Project by numbers". Genomics England. Archived from the original on 9 December 2018. Retrieved 2 October 2018.
  13. ↑ First children diagnosed in DNA project Archived 6 July 2018 at the Wayback Machine by James Gallagher published by BBC News on 12 January 2016
  14. ↑ Fergus Walsh: Faster diagnosis from 'transformational' gene project Archived 5 December 2018 at the Wayback Machine 5 December 2018, bbc.co.uk/news, accessed 5 December 2018
  15. ↑ "Over 100,000 whole genome sequences now available for approved researchers | Genomics England". 31 July 2019. Archived from the original on 24 June 2021. Retrieved 16 June 2021.
  16. ↑ Lacaze, Paul; Fransquet, Peter; Tiller, Jane; Nunn, Jack S. (2019). "Public Involvement in Global Genomics Research: A Scoping Review". Frontiers in Public Health. 7: 79. doi: 10.3389/fpubh.2019.00079 . ISSN   2296-2565. PMC   6467093 . PMID   31024880.
  17. ↑ "Genomics England launches next-generation research platform central to UK COVID-19 response". 29 June 2020. Archived from the original on 15 May 2023. Retrieved 3 February 2023.
  18. ↑ Versel, Neil (8 February 2022). "Lifebit Counting on New UK Partnerships to Develop, Validate Federated Data Model". Archived from the original on 3 February 2023. Retrieved 3 February 2023.
  19. ↑ "Written evidence submitted by Genomics England (GEN0015)". Committees. January 2017. Retrieved 25 June 2024.
  20. ↑ "Evidence on Genomics and genome-editing". Committees. 1 April 2017. Retrieved 25 June 2024.
  21. ↑ "GenOMICC COVID-19 study | Genomics England". 4 May 2020. Archived from the original on 4 October 2021. Retrieved 4 October 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.